Search

Calmare NJ USA

Tag

chemo pain treatment

Meet 30 Calmare Therapy NJ Patients on YouTube

October 23, 2018

By Dr. Michael Cooney, Clinical Director, Calmare Therapy NJ USA

Most people who visit our website are already frustrated with the medical community.

They or a loved one are in pain.

Pain medication is not pain management, they have learned firsthand.

But a myriad of painful procedures, surgery and implanted devices have also failed to do their jobs.

Then what?

From unexplained neuropathy after surgery to diabetic neuropathy or pain after chemotherapy , too many people are left with unresolved neuropathy.

And they continue to lead debilitated lives, so unfairly.

I came to this conclusion years ago, which is what compelled me to launch Calmare scrambler, an FDA-cleared alternative therapy here in New Jersey in 2011.

Mayo Clinic Researchers Test Scrambler Therapy for Pain

It has no side effects, is painless to undergo. It’s drug-free. The worst case scenario is that the treatment does not work, which happens.

But in more than 75% of the patients we treat, their pain is significantly reduced–or eliminated.

Watch and listen to the patients for whom we have relieved severe chronic pain over the years–

From 10-year-old children to seniors who had battled neuropathy for decades, you will discover someone who has fought the same battle with pain that you do.

Then, we hope you’ll reach out via the contact form below, by emailing us at calmarenj@gmail.com or calling our clinic at (201) 933-4440.

Only Calmare Therapy NJ USA Supports Calmare with Diagnostic BrainSpan

Don’t give up. Keep fighting. The solution to your pain is close at hand.

https://www.youtube.com/user/CalmareTherapyNJ/videos

 

The difference between Calmare MC-5A technology and a TENS unit

January 16, 2017

emi-hewatt-having-calmare-treatment-_10-16Here at Calmare Therapy NJ, we’ve been using scrambler therapy since 2011. We’ve successfully treated hundreds of patients from more than 20 countries.

But the question in this headline is 100 percent valid and requires a detailed explanation. The difference between these two medical devices can be compared to driving on a freshly-paved 16-lane super highway versus a one-lane, gravel-covered back road. So from a patient’s perspective, let’s put these two pain treatment devices head-to-head.

The operational distinctions between the two devices are significant:

  • Volume of current being used
  • Type of neurons transmitting the no-pain signal
  • Calmare device sends a “no pain” signal on the surface C-fiber nerve receptors instead of interrupting pain signals through the A-beta fibers (tens unit).

Calmare® Pain Therapy’s MC-5A Technology

This technology creates a low-energy electrical impulse which travels through the patient’s nerves delivering a “no-pain” signal to the brain. This process “tricks the brain” that the area of pain is normal and eventually results in prolonged pain relief.

Calmare uses primarily “C Fibers” to transmit these random ‘no pain’ signals to calm the brain. It operates at 40 to 50 Hz. and 16 different algorithms deliver five duel-channel signals to restart the brain and ultimately disrupt the chronic pain loop.

There is never a repeated cycle during a treatment, so there can be no accommodation by the brain (as with drugs or a self-administered, hand-held TENS unit).

Calmare technology pain relief offers patients a significantly longer duration (often months, years or more) of lower (or even eliminated) pain relief as opposed to using a TENS unit, where the pain returns soon after discontinuation of the treatment.

Calmare Certified Location LogoFinally, Calmare Therapy is only administered by a medical professional who has years of clinical expertise delivering customized pain therapy.

The Calmare Device Earned a U.S. Patent Number

The scrambler machine has been awarded a patent from the U.S. Patent and Trademark Office which identifies the device as a unique entity, unlike anything else in the market (i.e. a tens unit). The U.S. Patent number is 8,380,317.

Lead Placement Performed by a Trained Pain Management Professional…or Self-administered by the Patient?

TENS unitThe small, hand-held TENS unit is self-administered by the patient, so the placement of the pads hand-during-treatmentis determined not by a healthcare professional, but at the best judgment of the patient or loved one providing the treatment at home. The TENS operates using a single signal, allowing for short duration pain relief. Most importantly, the machine has been designed with the goal of temporarily reducing pain.

RSD and CRPS Patients

The main challenge in treating RSD/CRPS is the complicated change in the nervous system which can be traced to changes in the receptors in the brain. As a result, therapy to resolve this kind of pain must reach the brain. The use of electricity for the management of pain is not unique to Calmare.

In fact, many RSD/CRPS sufferers have already tried traditional TENS therapy prior to coming to our clinic.

Calmare Therapy Does Not Function Like a TENS Unit

Calmare Technology 2012Injury or other noxious stimulus in the body creates pain chemicals. These chemicals, in turn, are converted into electrical impulses by your nerves which are transmitted to the brain and INTERPRETED by the brain. When specially-trainined doctors use Calmare Therapy, they “control” the electrical impulses that the brain is receiving.

By manipulating the input into the brain, they “retrain” it to remove the pain signal to the area of the body where there is, in fact, no pain.

Interesting, medical science has already proven through other methodologies that the brain can be “taught.” In medicine, we refer to those changes as neuroplasticity and there are many resources of interesting reading on that topic.

Questions? Call Us. We’ll Answer

nurses-on-phoneAdmittedly, this information is a lot to take in for people without a healthcare background. Nonetheless, we hope this helps in recognizing the key differences between the two devices.

If you have questions or would like to find out if Calmare Therapy might be right for your chronic pain condition,  call our friendly team at (201) 933-4440 or email us at calmarenj@gmail.com.

 

Medscape reports on another positive clinical trial using Calmare for cancer pain

medscapeAnother Calmare Therapy clinical trial, conducted with people battling neuropathic pain as a result of chemotherapy treatment, has again shown  positive patient outcomes (significant lessening of pain) according to a new report published this week by Medscape, an affiliate of WebMD. (You have to register to read the article, but the process is free, quick and easy).

clinical trialCalmare Trial Key Points / Excerpts:

  • Scrambler therapy was not originally developed for the treatment of cancer-related neuropathic pain. Rather, it was developed for chronic pain and, indeed, has been used in many patients with noncancer-related pain, including low back pain.
  • Regardless of the type of neuropathic pain being treated, scores on the 11-point Numerical Rating Scale (NRS) decreased significantly from baseline to 1-month follow-up (P < .001).
  • The need for ‘rescue opioids’ dropped from a baseline dose of 5 mg to 0 mg at the end of the study.
  • No adverse side effects (“events”) that could have been associated with the therapy were reported.
  • A research team from the Massey Cancer Center at Virginia Commonwealth University in Richmond reported similar findings using the same cutaneous electro-stimulation device (scrambler therapy) for CIPN (J Pain Symptom Manage. 2010;40:883-891).
  • Some patients relapsed, but re-treatment and maintenance therapy (booster treatments) provided relief and, again, no adverse effects from treatment were observed.
  • Charles Loprinzi, MD, PhD, from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a trial with 37 CIPN patients and achieved similar study outcomes (Support Care Cancer. 2015 23:943-951).
  • Dr. Loprinzi stated that people have been slow to explore scrambler therapy use because “it sounds too good to be true…” He also reported to Medscape that efforts to conduct larger trials are ongoing, but it takes time and money to perform these trials.

The European Journal of Oncology Nursing also published an abstract of the study reported by Medscape.


Charles Osgood reports on Mayo Clinic Calmare Trial

TheOsgoodFileThe highly regarded journalist Charles Osgood, author of the  long-running Osgood File, reported on a new clinical trial at Mayo Clinic featuring a woman who battled cancer with chemotherapy. Unfortunately, the treatment left her with a severe chronic pain condition called chemotherapy induced peripheral neuropathy (chronic pain) or CIPN.

The patient, Karen, had pain that was so severe she could barely walk.

She heard about a new treatment for chronic pain called scrambler therapy being offered at the Mayo Clinic and signed up. Once cleared for the trial, Karen began daily Calmare treatments, which are pain-free and have no side effects.

During the interview with Osgood, Karen reported that  Calmare started working after the very first treatment. After four treatments, the pain she had endured for more than a decade was gone.

“It wasosgood so incredible that I hadn’t felt pain-free for so many years that I guess I didn’t expect it to last,” Karen says during the interview.

More than a year after her treatment, she continues to be pain-free.

Dr. Loprinzi from Mayo Clinic reports outstanding outcomes using Calmare scrambler therapy

Reuters video image

By Dr. Michael J. Cooney

I was very pleased to see this national media report from reporter Ben Gruber at Reuters News Service about a doctor at Mayo Clinic who is achieving very positive cancer patient outcomes using Calmare scrambler therapy to treat post-treatment pain.

Chemotherapy-induced peripheral neuropathy is a common but extremely painful condition many cancer patients suffer from as a side effect after chemotherapy treatment. Finding successful pain management solutions to treat this debilitating pain have been particularly challenging.

mayo clinicBut Dr. Charles L. Loprinzi, a highly regarded oncologist and professor at  the Mayo Clinic, has been conducting clinical trials using scrambler therapy to help cancer patients for the past three years. Today, he’s sharing his positive findings with the national media about his success using the scrambler machine.

The majority of chronic pain patients we have seen here at Calmare Therapy NJ are being treated for severe chronic pain for additional neuropathic conditions —  fibromyalgia, shingles, complex regional pain syndrome (CRPS) and post-surgical pain.

The recovering cancer patients with CIPN we have treated to date have also experienced outstanding outcomes, however.

When no one can hear you scream…

September 27, 2012

Last week, a doctor blogger  wrote about the debilitating chronic pain an older patient was forced to endure after chemotherapy and radiation treatment in one of my favorite medical blogs, Well, in the New York Times,  He survived the cancer — but lives with never-ending pain.   

Calmare Therapy is (apparently) still little-known in the medical community. In fact, it is a non-invasive and highly successful treatment for chronic pain, particularly chemotherapy-induced peripheral neuropathy (CIPN).

I’m haunted by a statement in the article by the daughter of the patient cited who says, “I’ll never forget what my father had to go through,” she said, weeping. “I wouldn’t wish this on anyone.”

If only this man, his family, or, more importantly, his team of oncologists, surgeons and pharmacists had even an inkling about the benefits of Calmare Therapy for this kind of pain, this man’s quality of life could be so much better. If only.

For we lucky healthcare practioners who have seen people’s lives forever improved after Calmare treatment, reading these kinds of articles is like being in a room where no one can hear you scream…

To learn more about Calmare Therapy for CIPN pain:

More scrambler therapy clinical study news: American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) completed a clinical trial on the benefits of scrambler therapy to be presented June 1:

“Scrambler therapy appears to have a promising effect on post herpetic neuropathy (PHN) with prompt and continued relief and no side effects.” PHN is a chronic, painful burning condition affecting nerve fibers and skin.

Why is this important?

Continued independent clinical trial studies confirm that Calmare scramber therapy offers substantial and ongoing relief from several sources of chronic pain, including cancer and chemotherapy-related treatment.

Abstract:

Background: Post herpetic neuropathy (PHN) is common in cancer and hematologic malignancy patients. It can be debilitating and difficulty to treat effectively. Scrambler therapy, a patient-specific neurocutaneous stimulation device, can be effective in treating chemotherapy induced neuropathy (JPSM 2010) and other neuropathic pain (JPSM 2012).

Methods: We treated ten patients, 2 with cancer as their primary diagnosis, with refractory PHN Scrambler therapy at two institutions. Scrambler therapy was given as 30 minute sessions daily for 10 days. Pain was recorded before and after treatment.

Results: The patient mean age was 54 ± SD 13 years, 6 men and 4 women, with a mean duration of PHN for 15.6 months (range 2.5 to 48 months) without satisfactory relief despite conventional drugs. The average pain score rapidly diminished from 7.64 ± 1.46 at baseline to 0.42 ± 0.89 at one month, a 95% reduction, with continued relief at 2 and 3 months. Patients achieved maximum pain relief with less than 5 treatments.

Conclusions: Scrambler therapy appears to have a promising effect on PHN, with prompt and continued relief and no side effects. Further research is warranted.

Great article on Calmare by American News Report

March 21, 2012

So pleased to see the U.S. healthcare media recognizing the importance of Calmare Therapy (and taking the time to document the very positive clinical trial results at Massey Cancer Institute, U. of Wisconsin and Mayo Clinic!) This article, “Innovative Pain Device Relieves Chronic Pain Without Drugs”  is accurate and informative.  Looking for facts and documentation? Please see below (live links included):

Innovative Pain Device Relieves Chronic Pain Without Drugs

One of the greatest frustrations of patients and healthcare providers alike is dealing with pain, particularly chronic pain. And nowhere is this more apparent than for cancer patients who endured months or years of chemotherapy, and are left with peripheral neuropathy, a chronic pain condition.

Patients who have agonized through chronic pain say an emerging new treatment has improved their lives – without the use of painkilling drugs. “It’s just a miracle,” Michelle Jacobson, a breast cancer survivor, told a Rhode Island television station.

This non-invasive chronic pain solution is called the Calmare Pain Therapy Treatment. Calmare uses a biophysical “scrambler” device which transmits low doses of electricity through electrodes on the skin in order to block pain. In essence, the Calmare scrambler “tricks” the brain into thinking there isn’t pain.

Researcher, bioengineer, professor, and founder of the Delta Research & Development center in Rome, Giuseppe Marineo developed the Calmare scrambler. The device was named after the Italian word “calmare”, which means “to ease” or “to soothe”.

The Calmare scrambler is most often used for chemotherapy-induced peripheral neuropathy, which causes sensations of burning, numbness, aching, coldness, itching, and tingling. However, Calmare is also being used to treat other chronic pain conditions, including lower back pain, neck pain, diabetic pain, fibromyalgia, post-surgical pain, RSD (Reflex Sympathetic Dystrophy), and radiating pain.

The Calmare device was approved by the Food and Drug Administration in 2009, but is only available at 16 private pain clinics in the United States, mostly on the east coast. Wounded soldiers and veterans are also receiving Calmare Pain Therapy at the Walter Reed Army Medical Center and nearly a dozen other U.S. military facilities. The Department of Defense is seeking alternative forms of pain management to discourage the overuse of painkillers, which are widely used by injured veterans returning from Iraq and Afghanistan.

Medical professionals and clinical studies are reporting promising results from Calmare’s drug-free device.

In a clinical study at the University of Wisconsin, researchers found that Calmare scrambler therapy showed measurable results in helping patients with Chemotherapy Induced Pain Neuropathy. “This technology has consistently shown very impressive results in our blind study,” reports Toby Campbell, MD, chief of Palliative Medicine, University of Wisconsin. 

In a pilot trial of the Calmare device, Massey Cancer Center in Richmond, Virginia found a dramatic reduction in CIPN pain with no toxicity side effect. The 2010 study was published in the Journal of Pain and Symptom Management.

The Mayo Clinic is also requesting volunteers in a clinical trial using Calmare scrambler technology to analyze pain associated with post-herpetic neuralgia.

CIPN patient shares her experience with Calmare Therapy

February 15, 2012 – Amsterdam

(reprinted with patient permission)

A Letter from Nelia B (Condition: CIPN after Chemo Taxol Therapy)

For the past 2 1/2 years, I’ve been suffering from severe CIPN in my feet, after undergoing Taxol therapy for breast cancer. Three months after finishing the chemo, the neuropathy got much worse. Since then I’ve been on a high dose of pain medication (Gabapentin, Venlafaxine, Tramadol). Still my pain kept being at a level between 5 to 10. I also tried morphine patches, two painful and unsuccessful nerve blocks, cortisone injections, acupuncture, tens treatments and vitamin B12 shots. Nothing helped.

My doctors told me that my CIPN was chronic and not much else could be done about it. Meanwhile, I kept researching options and read about the clinical trials for CIPN with “Calmare Therapy” at the Massey Cancer Center, as well as at the University of Wisconsin (UW) Carbone Center. The doctors at both institutions told me that they experienced positive outcomes. I was also able to talk to a patient who underwent Calmare treatment, which was encouraging also. Then in the fall of 2011, I learned that the US Military opened several Calmare centers.

In December 2011, I decided to give it a try and contacted Dr. Cooney at the Rutherford Allied Medical Group in the United States. Afraid of being disappointed, I was a skeptical patient. But after the first treatment, my feet felt relaxed and I could sense a slight relief. Thereafter, I got better with every treatment and started cutting down the pain medication. After 10 treatments I was on 10% pain medication and the pain was at level 3 to 5. When I returned home the pain slightly increased, but then it stabilized. Although I am not pain free, I feel so much better.

The Calmare treatment has given me back some quality of live, I did not have in three years. I’ve much more energy, my head is clear–being on much less medication–and I feel hopeful! It’s great to be on the street and look down the block, knowing that I can actually walk there; it is even better that I can finally take my children to the playground. My family is very relieved seeing me feeling better.

I’m very grateful to have found the Rutherford Allied Medical Group in New Jersey. Thank you Dr. Cooney and Dr. Michel for the wonderful care!

If you suffer from CIPN, you absolutely should give it a try. Good luck!

Nelia B.

Blog at WordPress.com.

Up ↑

%d bloggers like this: